Neoadjuvant tislelizumab plus chemotherapy among patients with locally advanced cervical cancer: A prospective, single-arm, phase II trial

被引：0
|
作者：
Sheng, Jindong [1 ]
Liu, Wenxin [1 ]
Liu, Ruoyan [1 ]
Liu, Chunyan [1 ]
Wang, Bochang [1 ]
Liu, Xiangyu [1 ]
Xu, Changxiao [1 ]
Fu, Xin [1 ]
Wang, Ke [1 ]
机构：
[1] Tianjin Med Univ, Tianjin, Peoples R China
来源：
GYNECOLOGIC ONCOLOGY | 2024年 / 190卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
12
引用
收藏
页码：S14 / S14
页数：1
相关论文
共 50 条
  • [31] Neoadjuvant sintilimab plus chemotherapy for locally advanced resectable esophageal squamous cell carcinoma: a prospective, single-arm, phase II clinical trial (CY-NICE)
    Chen, Yuzhen
    Ren, Meiyu
    Li, Bin
    Meng, Yuqi
    Wang, Cheng
    Jiang, Peng
    Song, Tieniu
    Yang, Jianbao
    Zhu, Duojie
    Yu, Qiyao
    JOURNAL OF THORACIC DISEASE, 2023, 15 (12) : 6761 - 6775
  • [32] Tislelizumab combined with induction chemotherapy and concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma: A prospective, single-arm, phase II trial
    Li, M.
    Qu, S.
    Lan, G.
    Shi, M.
    Wang, Y.
    Ban, M.
    Weng, J.
    Wei, J.
    Huang, W.
    Gui, Z.
    Mao, X.
    Huang, X.
    Xie, S.
    Wang, H.
    Huang, B.
    Qin, Y.
    ANNALS OF ONCOLOGY, 2024, 35 : S632 - S632
  • [33] Neoadjuvant chemoradiotherapy plus tislelizumab followed by surgery for esophageal carcinoma (CRISEC study): the protocol of a prospective, single-arm, phase II trial
    Jinsong Yang
    Ai Huang
    Kunyu Yang
    Ke Jiang
    BMC Cancer, 23
  • [34] Neoadjuvant chemotherapy with FOLFOXIRI for high-risk relapsed locally advanced colon cancer: A single-arm phase II trial.
    Meng, Wenjian
    Qiu, Meng
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : 201 - 201
  • [35] Split-course hypofraction radiotherapy combined with chemotherapy and tislelizumab as preoperative treatment for locally advanced rectal cancer: Interim analysis of a prospective, single-arm phase II trial
    Zheng, R.
    Chen, S.
    Hong, Y.
    Huang, X.
    Shi, G.
    Chen, Z.
    Wang, L.
    Yang, Y.
    Jiang, W.
    Chi, P.
    Xu, B.
    ANNALS OF ONCOLOGY, 2024, 35 : S1435 - S1435
  • [36] Interim result of phase II, prospective, single-arm trial of long-course chemoradiotherapy combined with concurrent tislelizumab in locally advanced rectal cancer
    Gao, Jiale
    Zhang, Xiao
    Yang, Zhengyang
    Zhang, Jie
    Bai, Zhigang
    Deng, Wei
    Chen, Guangyong
    Xu, Rui
    Wei, Qi
    Liu, Yishan
    Han, Jiagang
    Li, Ang
    Liu, Gang
    Sun, Yi
    Kong, Dalu
    Yao, Hongwei
    Zhang, Zhongtao
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [37] Multi-omics analysis of tislelizumab plus nab-paclitaxel and cisplatin as neoadjuvant immunochemotherapy for locally advanced hypopharyngeal squamous cell carcinoma: A prospective single-arm phase II trial
    Xie, Z.
    Zhang, W.
    Chen, X.
    Wang, X.
    Liu, S.
    Yi, J.
    An, C.
    Lu, H.
    Yao, J.
    Zhu, H.
    Xie, T.
    Tang, L.
    He, X.
    Shi, Y.
    Gui, L.
    ANNALS OF ONCOLOGY, 2024, 35 : S641 - S641
  • [38] Prediction for major pathologic response after neoadjuvant tislelizumab combined with chemotherapy in patients with locally advanced esophageal squamous cell carcinoma by RNA sequencing: A single-arm, phase II trial
    Guo, Wei
    Wang, YingJian
    He, Yan
    Li, Kunkun
    Bao, Tao
    He, Xiandong
    Xie, Xianfeng
    Chen, Xv
    Pu, Xiangshu
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [39] Phase II trial of neoadjuvant chemotherapy followed by chemoradiation in locally advanced cervical cancer
    Alexandre Silva de Azevedo, Carla Rameri
    Santos Thuler, Luiz Claudio
    Gonsalves de Mello, Maria Julia
    de Oliveira Lima, Jurema Telles
    Fassizoli da Fonte, Ana Luiza
    Santos Fontao, Diogenes Fernando
    Gomes Carneiro, Vandre Cabral
    Cabral Chang, Tien Man
    Ferreira, Carlos Gil
    GYNECOLOGIC ONCOLOGY, 2017, 146 (03) : 560 - 565
  • [40] Clinical/biomarker data for neoadjuvant tislelizumab (TIS) plus chemotherapy (Chemo) in resectable locally advanced head and neck squamous cell carcinoma (LA-HNSCC): A single-arm, phase II trial
    Li, Q.
    Cai, L.
    Kuang, D.
    Pan, C.
    Zhao, J.
    Huang, P.
    He, C.
    Xu, K.
    Liu, D.
    Long, G.
    Liu, Z.
    Hu, G.
    Lu, X.
    ANNALS OF ONCOLOGY, 2024, 35 : S621 - S622
12345